Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study

Figure 4 Changes in inflammatory factors and lipopolysaccharide-binding protein after treatment in the two groups. The concentrations of interferon-inducible protein 10, tumour necrosis factor alpha, and lipopolysaccharide-binding protein showed a downtrend in the rifaximin group but uptrend in the control group, and interferon-inducible protein 10 decreased significantly in the rifaximin compared with the control group (Table 3). IL-6: Interleukin-6; IL-8: Interleukin-8; TNF-α: Tumour necrosis factor alpha; MCP-1: Monocyte chemoattractant protein-1; LBP: Lipopolysaccharide-binding protein; IP-10: Interferon-inducible protein 10.